{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:27:24Z","timestamp":1790270844693,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.dld.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T17:58:56Z","timestamp":1558029536000},"page":"922-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Familial intrahepatic cholestasis: New and wide perspectives"],"prefix":"10.1016","volume":"51","author":[{"given":"Giovanni","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranka","family":"Vukotic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Andreone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.04.013_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(60)91045-X","article-title":"Intermittent possibly familial intrahepatic cholestatic jaundice","volume":"1","author":"Tygstrup","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.04.013_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.dld.2019.04.013_bib0020","first-page":"570","article-title":"Progressive familial intrahepatic cholestasis","volume":"9","author":"Hori","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.dld.2019.04.013_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1872-034X.2012.01061.x","article-title":"Bile salt export pump deficiency: a de novo mutation in a child compound heterozygous for ABCB11. Laboratory investigation to study pathogenic role and transmission of two novel ABCB11 mutations","volume":"43","author":"Francalanci","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2019.04.013_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/liv.12910","volume":"36","author":"Gordo-Gilart","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.04.013_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-015-1110-z","article-title":"ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression","volume":"51","author":"Degiorgio","year":"2016","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"SIGENP Study Group for Genetic Cholestasis. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"Colombo","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2019.04.013_bib0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.dld.2019.04.013_bib0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2012.11.025","article-title":"Next-generation sequencing in the clinic: promises and challenges","volume":"340","author":"Xuan","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.dld.2019.04.013_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.mcp.2015.03.001","article-title":"Taking the next step forward \u2014 diagnosing inherited infantile cholestatic disorders with next generation sequencing","volume":"29","author":"Herbst","year":"2015","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.dld.2019.04.013_bib0070","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1026537","article-title":"Mutations in TJP2, encoding zona occludens 2, and liver disease","volume":"3","author":"Sambrotta","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.dld.2019.04.013_bib0075","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2019.04.013_bib0080","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.29020","article-title":"Defects in myosin VB are associated with a spectrum of previously undiagnosed low \u03b3-glutamyltransferase cholestasis","volume":"65","author":"Qiu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","article-title":"MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease","volume":"65","author":"Gonzales","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0030-1253221","article-title":"Progressive familial intrahepatic cholestasis type 1","volume":"30","author":"Paulusma","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPG.0b013e3181596060","article-title":"Update on progressive familial intrahepatic cholestasis","volume":"46","author":"Alissa","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2019.04.013_bib0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1651-2227.1986.tb10332.x","article-title":"Fatal familial cholestatic syndrome in Greenland Eskimo children","volume":"75","author":"Nielsen","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.dld.2019.04.013_bib0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jhep.2009.11.012","article-title":"Liver disease associated with canalicular transport defects: current and future therapies","volume":"52","author":"Stapelbroek","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Srivastava","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jpedsurg.2008.07.018","article-title":"Nontransplant surgical interventions in progressive familial intrahepatic cholestasis","volume":"44","author":"Davis","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.dld.2019.04.013_bib0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(03)00286-1","article-title":"Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation","volume":"39","author":"Lykavieris","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/515501","article-title":"Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24","volume":"61","author":"Strautnieks","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.dld.2019.04.013_bib0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","article-title":"The bile salt export pump (BSEP) in health and disease","volume":"36","author":"Kubitz","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.23083","article-title":"De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa0901075","article-title":"Recurrence of bile salt export pump deficiency after liver transplantation","volume":"361","author":"Jara","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.04.013_bib0150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/lt.22074","article-title":"Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease)","volume":"16","author":"Siebold","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.04.013_bib0155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep.28311","article-title":"Bile salt export pump-reactive antibodies form a polyclonal, multi-inhibitory response in antibody-induced bile salt export pump deficiency","volume":"63","author":"Stindt","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.27834","article-title":"Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2","volume":"62","author":"Varma","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0165","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jpeds.2013.12.032","article-title":"Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2","volume":"164","author":"Naoi","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2019.04.013_bib0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.27767","article-title":"Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: evidence for improvement of cholestasis with 4-phenylbutyrate","volume":"62","author":"Gonzales","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0175","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.bmcl.2012.04.099","article-title":"E297G mutated bile salt export pump (BSEP) function enhancers derived from GW4064: structural development study and separation from farnesoid X receptor-agonistic activity","volume":"22","author":"Misawa","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.dld.2019.04.013_bib0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2019.04.013_bib0190","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0195","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/jpet.104.079665","article-title":"Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis","volume":"313","author":"Fiorucci","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2019.04.013_bib0205","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","article-title":"Structural and functional hepatocyte polarity and liver disease","volume":"63","author":"Gissen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/00365521.2011.650191","article-title":"Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases","volume":"47","author":"Folvik","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0030-1253222","article-title":"The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease","volume":"30","author":"Lam","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1089-3261(03)00133-8","article-title":"Benign recurrent intrahepatic cholestasis","volume":"8","author":"Luketic","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.20998","article-title":"Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis","volume":"43","author":"Stapelbroek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0230","doi-asserted-by":"crossref","first-page":"10310","DOI":"10.1046\/j.1525-1594.2002.06822.x","article-title":"The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers","volume":"26","author":"Stange","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.dld.2019.04.013_bib0235","doi-asserted-by":"crossref","first-page":"22024","DOI":"10.1016\/S0022-3468(98)90435-3","article-title":"Ileal exclusion for Byler\u2019s disease: an alternative surgical approach with promising early results for pruritus","volume":"33","author":"Hollands","year":"1998","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.dld.2019.04.013_bib0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(01)00299-9","article-title":"Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum","volume":"36","author":"van Ooteghem","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0245","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2005.09.013","article-title":"A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2","volume":"44","author":"Lam","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0250","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/liv.12217","article-title":"A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis","volume":"33","author":"Stindt","year":"2013","journal-title":"Liv Int"},{"key":"10.1016\/j.dld.2019.04.013_bib0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bpg.2010.07.010","article-title":"Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy","volume":"24","author":"van der Woerd","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0260","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2015.11.030","article-title":"Pregnancy and liver disease","volume":"64","author":"Westbrook","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0270","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.04.013_bib0275","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1471-0528.2004.00167.x","article-title":"Clinical outcome in a series of cases of obstetric cholestasis identified via a padavittient support group","volume":"111","author":"Williamson","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.dld.2019.04.013_bib0280","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0285","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2005.09.017","article-title":"Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy","volume":"44","author":"Vallejo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0290","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3748\/wjg.15.897","article-title":"Liver disease in pregnancy","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0295","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.dld.2019.04.013_bib0300","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1253224","article-title":"Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy","volume":"30","author":"Pauli-Magnus","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.04.013_bib0305","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.21500","article-title":"Linkage between a new splicing site mutation in the MDR3 ABCB4 gene and intrahepatic cholestasis of pregnancy","volume":"45","author":"Schneider","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3283349eb0","article-title":"Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability","volume":"20","author":"Ho","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.dld.2019.04.013_bib0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00008571-200304000-00003","article-title":"Pharmacogenetics of hepatocellular transporters","volume":"13","author":"Pauli-Magnus","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.dld.2019.04.013_bib0320","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.gastro.2006.05.003","article-title":"Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy","volume":"131","author":"Keitel","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0325","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2004.058115","article-title":"ATP8B1 muhtations in British cases with intrahepatic cholestasis of pregnancy","volume":"54","author":"M\u00fcllenbach","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.04.013_bib0330","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.ejhg.5201355","article-title":"Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy","volume":"13","author":"Painter","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.dld.2019.04.013_bib0335","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","article-title":"Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy","volume":"133","author":"Van Mil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0340","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1478-3231.2009.02026.x","article-title":"Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy","volume":"29","author":"Zimmer","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.04.013_bib0345","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1038\/s41598-017-11626-x","article-title":"An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy","volume":"7","author":"Dixon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2019.04.013_bib0350","doi-asserted-by":"crossref","first-page":"e4949","DOI":"10.1097\/MD.0000000000004949","article-title":"Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a prisma-compliant study)","volume":"95","author":"Kong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2019.04.013_bib0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2015.03.020","article-title":"Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy","volume":"189","author":"Geenes","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.dld.2019.04.013_bib0360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0365","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0370","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0375","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21111","article-title":"Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study","volume":"43","author":"Ropponen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0380","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0385","doi-asserted-by":"crossref","first-page":"858","DOI":"10.5858\/arpa.2014-0229-RA","article-title":"Pathophysiology and diseases of the proximal pathways of the biliary system","volume":"139","author":"Nakanishi","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.dld.2019.04.013_bib0390","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.113.054189","article-title":"The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity","volume":"42","author":"Garzel","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dld.2019.04.013_bib0395","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1471-0528.2004.00167.x","article-title":"Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group","volume":"111","author":"Williamson","year":"2004","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.dld.2019.04.013_bib0400","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0016-5085(19)34313-6","article-title":"Biliary cirrhosis induced by chlorpromazine","volume":"51","author":"Walker","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0405","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Dr\u00f6ge","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.04.013_bib0410","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0415","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1472-8206.2008.00566.x","article-title":"Assessment of drug-induced liver injury in clinical practice","volume":"22","author":"Lucena","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dld.2019.04.013_bib0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"11","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2019.04.013_bib0425","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S2210-7401(12)70019-0","article-title":"Low phospholipid-associated cholestasis and cholelithiasis","volume":"36","author":"Erlinger","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0430","first-page":"368A","article-title":"Intrahepatic cholesterol cholelithiasis associated with ABCB4 gene mutations: phenotype-genotype relationship","volume":"42","author":"Rosmorduc","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0435","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0440","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.04.013_bib0445","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bpg.2006.05.009","article-title":"Gallstone disease: epidemiology, pathogenesis, and classi\ufb01cation of biliary stones (common bile duct and intrahepatic)","volume":"20","author":"Tazuma","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0450","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-230X-10-30","article-title":"Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis","volume":"10","author":"Bass","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2019.04.013_bib0455","first-page":"4765","article-title":"BA as carcinogens in human gastrointestinal cancers","volume":"589","author":"Bernstein","year":"2005","journal-title":"Mut Res"},{"key":"10.1016\/j.dld.2019.04.013_bib0460","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2019.04.013_bib0465","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole-genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.dld.2019.04.013_bib0470","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.27872","article-title":"Hepatocellular carcinoma associated with tight-junction protein 2 deficiency","volume":"62","author":"Zhou","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.04.013_bib0475","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","article-title":"Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice","volume":"28","author":"Kim","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dld.2019.04.013_bib0480","doi-asserted-by":"crossref","first-page":"11203","DOI":"10.1038\/s41598-017-11549-7","article-title":"Long-term administration of nuclear bile acid receptor FXR agonist prevents spontaneous hepatocarcinogenesis in Abcb4-\/- mice","volume":"7","author":"Cariello","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2019.04.013_bib0485","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/bjc.2017.352","article-title":"Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence","volume":"117","author":"Letellier","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2019.04.013_bib0490","doi-asserted-by":"crossref","first-page":"e39469","DOI":"10.1371\/journal.pone.0039469","article-title":"Deregulation of Rab and Rab effector genes in bladder cancer","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.04.013_bib0495","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s10620-013-2600-6","article-title":"MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer","volume":"58","author":"Dong","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2019.04.013_bib0500","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/genes1010038","article-title":"Review next generation DNA sequencing and the future of genomic medicine","volume":"1","author":"Anderson","year":"2010","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.dld.2019.04.013_bib0505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clinre.2014.03.010","article-title":"Cholestasis in the newborn and infant","volume":"38","author":"Fischler","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:10:19Z","timestamp":1761624619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819305535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":101,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1590865819305535"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.04.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial intrahepatic cholestasis: New and wide perspectives","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}